IMODE is organising its second annual convention during BioFIT with a morning of conferences and participation in the BioFIT one-to-one meetings during the afternoon.

PROGRAMME | December 4th 

8.30 – 9.30 AM
Name badge pickup and Welcome coffee – BioFIT

9.30 – 10.00 AM
IMODE overall presentation

Pr. Frédéric Affouard
University of Lille, UMET Laboratory, IMODE’s coordinator

10.00 – 10.30 AM
Electrospinning approach for drug delivery

Dr. Stéphanie Degoutin
University of Lille, UMET Laboratory

10.30 – 11.00 AM
Nanostructured materials: The next generation of active stents vessels

Dr. Ariane Boudier
University of Lorraine, Director of CITHEFOR Laboratory

11.00 – 11.30 AM
Networking break – BioFIT 

11.30 AM – 12.00 PM
Tissue Engineering approach

Dr. Nicolas L’Heureux
University of Bordeaux, Director of BioTis Laboratory

12.00 – 12.30 PM
Regenerative medicine approach

Dr. Laurence Bordenave
CHU Bordeaux, Head of Nuclear Medicine

12.30 – 1.00 PM
Cardiovascular Disease, Restenosis and Thrombosis

Dr. Blandine Maurel
CHU Nantes, Vascular surgeon

1.00 – 2.30 PM
Lunch – BioFIT

1.00 – 6.30 PM
One-to-one meetings – BioFIT


Registration to the IMODE convention is free but mandatory. It gives you a free access for the afternoon of the 4th of December at BioFIT.

By participating to IMODE convention, you obtain a 50% discount on your BioFIT pass for the day of December 5th. Please contact Margaux Satola to obtain your coupon code.


IMODE is a collaborative research project for multicomponent pharmaceutical products (co-amorphous and co-crystals) and medical devices that are loaded with bioactive molecules. Started in 2016, the IMODE project is funded by the European Interreg 2 Seas programme and co-financed by the European Fund for Regional Development (EFRD).

The project’s overall objective is to bring together the specific transdisciplinary skills and experiences of partners (academic research groups, development agencies, SMEs) in order to provide the 2 Seas Area with strategic advantages for innovative pharmaceutical and medical applications. The IMODE project is motivated by an unmet need to develop solutions to addressing societal challenges to improve healthcare and provide novel and effective medication for various cardiovascular or gastro-intestinal conditions that lack or have inadequate treatment, all while keeping medical costs low.

More information about IMODE:

IMODE partners: